Israeli researchers say they have used a small molecule to induce the self-destruction of pancreatic cancer cells in mice. The treatment reduced the number of cancer cells by as much as 90 percent a month after being administered, according to their study.
The research holds “great potential for the development of a new effective therapy to treat this aggressive cancer in humans,” Tel Aviv University said in a statement.
See if this may be a treatment option for you
The paper was published in the October issue of the journal Oncotarget, a peer-reviewed biomedical journal that covers oncology research. The journal is a lesser-known publication within the academic world, and the studies it publishes generally have a lower impact factor than those published in leading medical journals like The New England Journal of Medicine, Nature or The Lancet. (Impact factor is the number of times a published article has been cited in a year, divided by the total number of articles published in the previous two years.)